Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity-Reference-Cited by-同舟云学术

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

Published:2007-07 Issue:7 Volume:6 Page:2012-2021
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Kumar Rakesh,Knick Victoria B.,Rudolph Sharon K.,Johnson Jennifer H.,Crosby Renae M.,Crouthamel Ming-Chih,Hopper Teresa M.,Miller Charles G.,Harrington Laura E.,Onori James A.,Mullin Robert J.,Gilmer Tona M.,Truesdale Anne T.,Epperly Andrea H.,Boloor Amogh,Stafford Jeffrey A.,Luttrell Deirdre K.,Cheung Mui

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 457 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful pazopanib treatment of undifferentiated pleomorphic sarcoma with coamplification of PDGFRA, VEGFR2 and KIT: A case report;Molecular and Clinical Oncology;2024-07-29

2. Efficacy of Pazopanib on Primary Patient-derived Undifferentiated Malignant Round Cell Sarcoma Line;Advances in Human Biology;2024-06-11

3. Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer;Biomedicines;2024-05-17

4. Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents;Cell Communication and Signaling;2024-04-15

5. Efficacy of tyrosine kinase inhibitors in patients with advanced or metastatic sarcomas after prior chemotherapy: A meta-analysis;Medicine;2024-03-15